These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 33766595)
21. Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process. Dana P; Kariya R; Vaeteewoottacharn K; Sawanyawisuth K; Seubwai W; Matsuda K; Okada S; Wongkham S Oncol Res; 2017 Aug; 25(7):1047-1059. PubMed ID: 28244853 [TBL] [Abstract][Full Text] [Related]
22. Targeting of Survivin Pathways by YM155 Inhibits Cell Death and Invasion in Oral Squamous Cell Carcinoma Cells. Zhang W; Liu Y; Li YF; Yue Y; Yang X; Peng L Cell Physiol Biochem; 2016; 38(6):2426-37. PubMed ID: 27287458 [TBL] [Abstract][Full Text] [Related]
23. CD147 confers temozolomide resistance of glioma cells via the regulation of β-TrCP/Nrf2 pathway. Bu X; Qu X; Guo K; Meng X; Yang X; Huang Q; Dou W; Feng L; Wei X; Gao J; Sun W; Chao M; Han L; Hu Y; Shen L; Zhang J; Wang L Int J Biol Sci; 2021; 17(12):3013-3023. PubMed ID: 34421346 [No Abstract] [Full Text] [Related]
24. The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature. Xiong L; Edwards CK; Zhou L Int J Mol Sci; 2014 Sep; 15(10):17411-41. PubMed ID: 25268615 [TBL] [Abstract][Full Text] [Related]
25. Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis. Jin J; Wang SJ; Cui J; Li L; Li JY; Liu FL; Sun XX; Jiang JL; Cui HY; Chen ZN Cell Oncol (Dordr); 2019 Aug; 42(4):537-554. PubMed ID: 31016558 [TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo synergistic anti-tumor effect of LIN28 inhibitor and metformin in oral squamous cell carcinoma. Chen H; Sa G; Li L; He S; Wu T Eur J Pharmacol; 2021 Jan; 891():173757. PubMed ID: 33249080 [TBL] [Abstract][Full Text] [Related]
28. A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells. Fu ZG; Wang L; Cui HY; Peng JL; Wang SJ; Geng JJ; Liu JD; Feng F; Song F; Li L; Zhu P; Jiang JL; Chen ZN Oncotarget; 2016 Feb; 7(8):9429-47. PubMed ID: 26882566 [TBL] [Abstract][Full Text] [Related]
29. [Effect of circular RNA hsa_circ_0008898 on oral squamous cell carcinoma and its mechanism]. Zhou HX; Wang LY; Chen S; Wang DD; Fang Z Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Aug; 55(8):578-585. PubMed ID: 32842350 [No Abstract] [Full Text] [Related]
30. CD147 promotes collective invasion through cathepsin B in hepatocellular carcinoma. Wang SJ; Chao D; Wei W; Nan G; Li JY; Liu FL; Li L; Jiang JL; Cui HY; Chen ZN J Exp Clin Cancer Res; 2020 Jul; 39(1):145. PubMed ID: 32727598 [TBL] [Abstract][Full Text] [Related]
31. Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin β1 to modulate malignant properties of hepatoma cells. Li Y; Wu J; Song F; Tang J; Wang SJ; Yu XL; Chen ZN; Jiang JL J Biol Chem; 2012 Feb; 287(7):4759-72. PubMed ID: 22130661 [TBL] [Abstract][Full Text] [Related]
32. Ubiquitin-specific protease TRE17/USP6 promotes tumor cell invasion through the regulation of glycoprotein CD147 intracellular trafficking. Ogura Y; Ohbayashi N; Kanaho Y; Kawaguchi A; Funakoshi Y J Biol Chem; 2022 Sep; 298(9):102335. PubMed ID: 35926707 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of CD147 expression reduces tumor cell invasion in human prostate cancer cell line via RNA interference. Wang L; Wu G; Yu L; Yuan J; Fang F; Zhai Z; Wang F; Wang H Cancer Biol Ther; 2006 Jun; 5(6):608-14. PubMed ID: 16627983 [TBL] [Abstract][Full Text] [Related]
34. CD147-dependent heterogeneity in malignant and chemoresistant properties of cancer cells. Dai L; Guinea MC; Slomiany MG; Bratoeva M; Grass GD; Tolliver LB; Maria BL; Toole BP Am J Pathol; 2013 Feb; 182(2):577-85. PubMed ID: 23178078 [TBL] [Abstract][Full Text] [Related]
35. Pseudolaric Acid B Inhibits Proliferation, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma Through Regulating CD147. Yin Z; Cai H; Wang Z; Jiang Y Drug Des Devel Ther; 2020; 14():4561-4573. PubMed ID: 33149553 [TBL] [Abstract][Full Text] [Related]
36. [RNAi-mediated silencing of CD147 inhibits the proliferation and infiltrations of leukemic cells SHI-1]. Tu Y; Li Z; Tang A; Fei Y; Li H; Wu Q; He W Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):737-42. PubMed ID: 25152124 [TBL] [Abstract][Full Text] [Related]
37. Expression of CD147 in advanced non-small cell lung cancer correlated with cisplatin-based chemotherapy resistance. Zeng HZ; Qu YQ; Liang AB; Deng AM; Zhang WJ; Xiu B; Wang H; Wang H Neoplasma; 2011; 58(5):449-54. PubMed ID: 21745000 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to cisplatin in laryngeal carcinoma Hep2 cells. Zhu C; Pan Y; He B; Wang B; Xu Y; Qu L; Bao Q; Tian F; Wang S Oncol Rep; 2011 Feb; 25(2):425-32. PubMed ID: 21165561 [TBL] [Abstract][Full Text] [Related]
39. CD147 knockdown improves the antitumor efficacy of trastuzumab in HER2-positive breast cancer cells. Xiong L; Ding L; Ning H; Wu C; Fu K; Wang Y; Zhang Y; Liu Y; Zhou L Oncotarget; 2016 Sep; 7(36):57737-57751. PubMed ID: 27363028 [TBL] [Abstract][Full Text] [Related]
40. Identification of CD147 (basigin) as a mediator of trophoblast functions. Lee CL; Lam MP; Lam KK; Leung CO; Pang RT; Chu IK; Wan TH; Chai J; Yeung WS; Chiu PC Hum Reprod; 2013 Nov; 28(11):2920-9. PubMed ID: 24014600 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]